
Syncell is a commercial-stage life science company focused on subcellular protein purification and unbiased spatial proteomics analysis. Syncell has commercialized its Microscoop® technology, helping researchers accurately discover new protein components from targeted regions of interest. To date, the company has raised $40 million from investors.